APA (7th ed.) Citation

United States. Congress. House. Committee on Government Operations, ProQuest (Firm), & United States. Congress. House. (1984). Deficiencies in FDA's Regulation of the Marketing of Unapproved New Drugs: The Case of E-Ferol. [publisher not identified].

Chicago Style (17th ed.) Citation

United States. Congress. House. Committee on Government Operations, ProQuest (Firm), and United States. Congress. House. Deficiencies in FDA's Regulation of the Marketing of Unapproved New Drugs: The Case of E-Ferol. Washington: [publisher not identified], 1984.

MLA (9th ed.) Citation

United States. Congress. House. Committee on Government Operations, et al. Deficiencies in FDA's Regulation of the Marketing of Unapproved New Drugs: The Case of E-Ferol. [publisher not identified], 1984.